Skip to main content
BAX
NYSE Life Sciences

Baxter Posts $294M Third-Quarter Net Income

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$26.5
Mkt Cap
$13.163B
52W Low
$15.73
52W High
$30
52W Position info
68% above low
Off High info
12% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

BAX sits 68% above its 52-week low of $15.73 on elevated volume (1.9× avg).

Summary

Baxter reported third-quarter net income of $294 million, with EPS of 57 cents and adjusted EPS of 58 cents on sales of $2.98 billion. The company guided to full-year adjusted EPS of $2.05 to $2.15 and raised its full-year 2026 outlook to reported sales growth of 4% to 5% and adjusted EPS of $2.05 to $2.15, and it declared a $0.01 quarterly dividend payable January 4, 2027. The results give a clearer read-through versus Q2's $2.96B sales and $0.56 adjusted EPS. Context matters here: the company has been actively reshaping its balance sheet, upsizing a debt tender to $600 million in August and loosening its net leverage covenant, and it installed John Rogers as permanent CFO effective October 1.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Baxter raised its full-year 2026 outlook: reported sales growth of 4% to 5% and adjusted EPS of $2.05 to $2.15, and declared a $0.01 quarterly dividend payable January 4, 2027.

At the time of this announcement, BAX was trading at $26.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $15.73 to $30.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

BAX - Latest Insights

BAX
Oct 29, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.94
Real-time Price: $26.01 info
Change: +$3.07 (+13%) info
Market Cap: $13.448B info
BAX
Oct 29, 2026, 8:06 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $26.00
Real-time Price: $26.01 info
Change: +$0.010 (+0.04%) info
Market Cap: $13.448B info
BAX
Oct 29, 2026, 7:18 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.74
Real-time Price: $26.01 info
Change: -$0.730 (-3%) info
Market Cap: $13.448B info
BAX
Aug 19, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.20
Real-time Price: $26.01 info
Change: -$0.190 (-0.73%) info
Market Cap: $13.448B info
BAX
Aug 18, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.88
Real-time Price: $26.01 info
Change: +$0.130 (+0.50%) info
Market Cap: $13.448B info